1. Home
  2. Analysis
  3. Melatonin
  4. Computerised-tomogram-abnormal

Melatonin and Computerised tomogram abnormal - a phase IV clinical study of FDA data

Summary:

Computerised tomogram abnormal is reported as a side effect among people who take Melatonin (melatonin), especially for people who are female, 50-59 old, also take Amlodipine, and have Breast cancer.

The phase IV clinical study analyzes which people have Computerised tomogram abnormal when taking Melatonin. It is created by eHealthMe based on reports of 53,570 people who have side effects when taking Melatonin from the FDA, and is updated regularly.

What is Melatonin?

Melatonin has active ingredients of melatonin. It is often used in insomnia. eHealthMe is studying from 56,204 Melatonin users. Check the latest studies of Melatonin.

What is Computerised tomogram abnormal?

Computerised tomogram abnormal is found to be associated with 688 drugs and 649 conditions by eHealthMe. Check the latest studies of Computerised tomogram abnormal.

On Dec, 17, 2025

53,570 people reported to have side effects when taking Melatonin.
Among them, 22 people (0.04%) have Computerised tomogram abnormal.

Could Melatonin cause Computerised tomogram abnormal?

Among these 22 people:

What is the gender of people who have Computerised tomogram abnormal when taking Melatonin? *

  • female: 92.31 %
  • male: 7.69 %

What is the age of people who have Computerised tomogram abnormal when taking Melatonin? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 100 %
  • 60+: 0.0 %

What are other drugs people take besides Melatonin? *

  1. Amlodipine: 18 people, 81.82%
  2. Zopiclone: 17 people, 77.27%
  3. Ativan: 17 people, 77.27%
  4. Afinitor: 17 people, 77.27%
  5. Kadcyla: 17 people, 77.27%
  6. Xeloda: 17 people, 77.27%
  7. Zometa: 15 people, 68.18%
  8. Zingiber Officinale: 10 people, 45.45%
  9. Vitamin C: 8 people, 36.36%
  10. Gemcitabine: 6 people, 27.27%

What are other side effects people have besides Computerised tomogram abnormal? *

  1. Nausea (feeling of having an urge to vomit): 20 people, 90.91%
  2. Fatigue (feeling of tiredness): 20 people, 90.91%
  3. Pain: 19 people, 86.36%
  4. Nasopharyngitis (inflammation of the nasopharynx): 18 people, 81.82%
  5. Stress And Anxiety: 18 people, 81.82%
  6. Infusion Related Reaction: 17 people, 77.27%
  7. High Blood Pressure: 17 people, 77.27%
  8. Muscle Aches (muscle pain): 17 people, 77.27%
  9. Kidney Stones: 17 people, 77.27%
  10. Inflammation: 17 people, 77.27%

What are the existing conditions these people have? *

  1. Breast Cancer Metastatic: 17 people, 77.27%
  2. Breast Cancer: 17 people, 77.27%
  3. Ovarian Cancer (cancer of ovary): 4 people, 18.18%
  4. Stress And Anxiety: 1 person, 4.55%
  5. Nightmares (unpleasant dreams): 1 person, 4.55%
  6. Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Melatonin and have Computerised tomogram abnormal?

- Check whether Computerised tomogram abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Melatonin:

Computerised tomogram abnormal treatments and more:

How severe was Computerised tomogram abnormal and when was it recovered:

Expand to all the drugs that have ingredients of melatonin:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Melatonin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Computerised tomogram abnormal:

Browse all the conditions that are associated with Computerised tomogram abnormal:

Drugs similar to Melatonin and Computerised tomogram abnormal :

How the study uses the data?

The study uses data from the FDA. It is based on melatonin (the active ingredients of Melatonin) and Melatonin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2025 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.